Loading...
Loading...
LIVN| Name | Value |
|---|---|
| Revenues | 318.6M |
| Cost of Revenue | 98.2M |
| Gross Profit | 220.4M |
| Operating Expense | 173.9M |
| Operating I/L | 46.5M |
| Other Income/Expense | -24.9M |
| Interest Income | 7.3M |
| Pretax | 21.6M |
| Income Tax Expense | 5.2M |
| Net Income/Loss | 16.3M |
LivaNova PLC is a global medical device company that generates revenue through the design, development, manufacturing, and sale of therapeutic solutions. The company operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment focuses on products such as oxygenators, heart-lung machines, autotransfusion systems, and perfusion tubing systems. The Neuromodulation segment markets the VNS Therapy System for drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. The Advanced Circulatory Support segment specializes in temporary life support products. LivaNova serves healthcare professionals and institutions through direct sales and independent distributors.
